DEFINE: CETP Inhibition with Anacetrapib Significantly Raises HDL Cholesterol and Further Lowers LDL

Article Information

DOI 
http://dx.doi.org/10.1177/155989771010005
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2010 MD Conference Express

Author Information

  1. Maria Vinall
  1. Christopher P. Cannon, MD
    1. Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015700
May 2015100
Jun 2015100
Jul 2015111
Aug 2015200
Sep 2015100
Oct 2015133
Nov 2015100
Total1544

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
DEFINE: CETP Inhibition with Anacetrapib Significantly Raises HDL Cholesterol and Further Lowers LDL
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Lipid Disorders